Log In
BCIQ
Print this Print this
 

YHB1411-2

  Manage Alerts
Collapse Summary General Information
Company Yuhan Corp.
DescriptionAnti-tumor necrosis factor (TNF) alpha antibody
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today